MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, AKBA has $364,152K in assets. $322,560K in debts. $166,444K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
193.69%
Quick Ratio
179.71%
Cash Ratio
124.79%
Debt to Asset Ratio
88.58%
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Goodwill
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Balance Sheets
2025-09-30
2025-06-30
Cash and cash equivalents
166,444 137,308
Inventories
18,643 16,708
Accounts receivable, net
66,223 72,809
Prepaid expenses and other current assets
7,026 7,832
Total current assets
258,336 234,657
Property and equipment, net
1,473 1,714
Operating right-of-use assets
4,837 5,987
Goodwill
59,044 59,044
Other long-term assets
40,462 44,193
Total assets
364,152 345,595
Accounts payable
10,087 11,554
Accrued expenses and other current liabilities
106,420 91,615
Current portion of deferred revenue
3,881 5,532
Working capital fund liability, current portion
12,991 10,016
Total current liabilities
133,379 118,717
Long-term operating lease liabilities
0 671
Long-term debt, net
47,641 47,062
Liability related to settlement royalties, net of current portion
52,994 48,729
Liability related to sale of future royalties, net of current portion
50,576 51,082
Working capital fund liability, net of current portion
27,726 30,556
Warrant liability
5,242 14,199
Other long-term liabilities
5,002 5,355
Total liabilities
322,560 316,371
Common stock 0.00001 par value 350,000,000 shares authorized at september30, 2025 and december 31, 2024 265,226,038 and 224,848,992 shares issued and outstanding at september30, 2025 and december31, 2024, respectively
2 2
Additional paid-in capital
1,713,045 1,701,217
Accumulated other comprehensive income
6 6
Accumulated deficit
-1,671,461 -1,672,001
Total stockholders' equity (deficit)
41,592 29,224
Total liabilities and stockholders' equity (deficit)
364,152 345,595
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Prepaid expenses andother current assets$7,026K Accounts receivable, net$66,223K Inventories$18,643K Cash and cashequivalents$166,444K Other long-termassets$40,462K Goodwill$59,044K Operating right-of-useassets$4,837K Property and equipment,net$1,473K Total current assets$258,336K Total assets$364,152K Total liabilities andstockholders' equity...$364,152K Total stockholders'equity (deficit)$41,592K Total liabilities$322,560K Accumulated deficit-$1,671,461K Accumulated othercomprehensive income$6K Additional paid-in capital$1,713,045K Other long-termliabilities$5,002K Warrant liability$5,242K Working capital fundliability, net of current...$27,726K Liability related to saleof future...$50,576K Liability related tosettlement royalties, net...$52,994K Long-term debt, net$47,641K Total currentliabilities$133,379K Common stock 0.00001par value...$2K Working capital fundliability, current portion$12,991K Current portion ofdeferred revenue$3,881K Accrued expenses andother current...$106,420K Accounts payable$10,087K

Akebia Therapeutics, Inc. (AKBA)

Akebia Therapeutics, Inc. (AKBA)